Nu-Med Plus (NUMD) Enterprise Value Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 79.18% |
| Sep 30, 2025 | -45.84% |
| Mar 31, 2025 | 2.20% |
| Dec 31, 2024 | 41.20% |
| Sep 30, 2024 | 49.75% |
| Jun 30, 2024 | 61.86% |
| Mar 31, 2024 | 64.26% |
| Dec 31, 2023 | 66.95% |
| Sep 30, 2023 | 29.39% |
| Jun 30, 2023 | -69.92% |
| Mar 31, 2023 | -42.49% |
| Dec 31, 2022 | -117.86% |
| Sep 30, 2022 | 75.33% |
| Mar 31, 2022 | 52.23% |
| Dec 31, 2021 | 58.85% |
| Sep 30, 2021 | 42.59% |
| Jun 30, 2021 | 36.79% |
| Mar 31, 2021 | 20.33% |
| Dec 31, 2020 | 18.72% |
| Sep 30, 2020 | 57.47% |
| Jun 30, 2020 | 71.49% |
| Mar 31, 2020 | 61.27% |
| Dec 31, 2019 | 17.15% |
| Sep 30, 2019 | -211.59% |
| Jun 30, 2019 | 25.43% |
| Mar 31, 2019 | 35.72% |
| Dec 31, 2018 | -75.66% |
| Sep 30, 2018 | -827.33% |
| Jun 30, 2018 | -199.75% |
| Mar 31, 2018 | -176.84% |
| Dec 31, 2017 | -84.09% |
| Sep 30, 2017 | -93.76% |
| Jun 30, 2017 | -88.46% |
| Mar 31, 2017 | -244.02% |
| Dec 31, 2016 | 2.00% |
| Sep 30, 2016 | 45.06% |
| Jun 30, 2016 | -66.13% |
| Mar 31, 2016 | -186.78% |
| Dec 31, 2015 | -248.36% |
| Sep 30, 2015 | -4.48% |
| Jun 30, 2015 | 14.19% |
| Mar 31, 2015 | 39.61% |
| Dec 31, 2014 | -301.41% |